novartis-check.com | Product Validation

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.novartis-check.com/sitemap.xml

Meta Tags

Title	Product Validation \| Verify Novartis
Description	Protect yourself from Магазин PARTNERSHIP Protect yourself from fakes Product Validation Protecting Patients: The Fight Against Counterfeit Medicines Illegal trade in counterfe
Keywords	N/A

Server Information

WebSite	novartis-check.com
Host IP	185.230.63.107
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

novartis-check.com Valuation

US$1,061

Last updated: 2022-12-09 17:08:29

novartis-check.com has Semrush global rank of 0. novartis-check.com has an estimated worth of US$ 1,061, based on its estimated Ads revenue. novartis-check.com receives approximately 122 unique visitors each day. Its web server is located in -, with IP address 185.230.63.107. According to SiteAdvisor, novartis-check.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,061
Daily Ads Revenue	US$0
Monthly Ads Revenue	US$29
Yearly Ads Revenue	US$352
Daily Unique Visitors	8
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
novartis-check.com.	A	3600	IP: 185.230.63.107
novartis-check.com.	A	3600	IP: 185.230.63.171
novartis-check.com.	A	3600	IP: 185.230.63.186
novartis-check.com.	NS	86400	NS Record: ns3.wixdns.net.
novartis-check.com.	NS	86400	NS Record: ns2.wixdns.net.
novartis-check.com.	MX	3600	MX Record: 10 mx1.timeweb.ru.

HtmlToTextCheckTime:2022-12-09 17:08:29

Магазин PARTNERSHIP Protect yourself from fakes Product Validation Protecting Patients: The Fight Against Counterfeit Medicines Illegal trade in counterfeit and substandard medicines is rising. Patients’ lives are at stake, and so is their trust in medication. At the same time, the costs to local and national economies and healthcare systems are immense. Pharmaceutical companies, law enforcement authorities and healthcare stakeholders are joining forces to tackle this global problem and ensure access to medicines means patients receive reliable, safe and effective pharmaceuticals. -14:33 Listen to audio version (14:33) Myanmar, 2005: More than half a million people were infected with malaria. So it was not surprising when, in February, a young man went to a local hospital with a high fever. He complained of headaches, chills and nausea. The doctors diagnosed malaria right away and prescribed artesunate, an antimalarial agent1. The young man’s symptoms should have disappeared after a

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Fri, 09 Dec 2022 08:51:01 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.novartis-check.com/
strict-transport-security: max-age=3600
x-wix-request-id: 1670575861.4161145786156425113
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=84
X-Seen-By: qdrMdw4zrP0/E6B8JtgqKA==,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVjdBAsm5Jhv6CBqo4CRiWQS,m0j2EEknGIVUW/liY8BLLletGEKvLVzie0xVdA3MK9EFJmEKNgQ96+wiTVoMq713,2d58ifebGbosy5xc+FRalkTw6tC+TZURzJ5zEcmXSni4HHtC9S0m2NTsUWrOAA/mRAj0HV4sXSG7TTQTVM8+HQ==,2UNV7KOq4oGjA5+PKsX47MdJv1/G+LJc9pECK3QqD6tYgeUJqUXtid+86vZww+nL,7npGRUZHWOtWoP0Si3wDp+hfs1rivG7/v7T+EhRgHXY=,xTu8fpDe3EKPsMR1jrheEBdxjqWc1MmWu1gp7lRpr9I=,UCcefuQCi27dXmJSD6Vpiwasw/ojTZ5PYWfZlrE0ZHY/VimRsmoinNpuA3PQOkt6Vnd8Z4jLK9R467MyhrzM6w==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Fri, 09 Dec 2022 08:51:01 GMT
content-type: text/html; charset=UTF-8
content-length: 389265
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"ef160947f8d89294ab6afb7f3f1b4939"
content-language: en-US
strict-transport-security: max-age=3600
age: 4512
x-seen-by: GXNXSWFXisshliUcwO20NZL9Lwun+M+7c/tw2Pto8/HKc4QZggpeMqiUS6WZHh7p,qquldgcFrj2n046g4RNSVLSYOfwSKEWbStkC9FaM8w8=,2d58ifebGbosy5xc+FRalopA1+ws0JMxKyZqPmygfWcy8NbzzZnZ+3MzjGNquHZYEQ+kwAkbhrBM0pumcIm/ZXOhAuWWUedb0DpQtsRHt8U=,2UNV7KOq4oGjA5+PKsX47H9uI8JOdunVpSRDzMPCPTFYgeUJqUXtid+86vZww+nL
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1670575861.647303138428674
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=euw1_g; Max-Age=20; Expires=Fri, 09 Dec 2022 08:51:21 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=euw1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

novartis-check.com Whois Information

Domain Name: NOVARTIS-CHECK.COM
Registry Domain ID: 2735526281_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.PublicDomainRegistry.com
Registrar URL: http://www.publicdomainregistry.com
Updated Date: 2022-11-11T13:59:06Z
Creation Date: 2022-10-31T07:18:30Z
Registry Expiry Date: 2023-10-31T07:18:30Z
Registrar: PDR Ltd. d/b/a PublicDomainRegistry.com
Registrar IANA ID: 303
Registrar Abuse Contact Email: abuse-contact@publicdomainregistry.com
Registrar Abuse Contact Phone: +1.2013775952
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS2.WIXDNS.NET
Name Server: NS3.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-12-09T08:39:53Z <<<

novartis-check.com valuation and analysis